Why Is Vanda Pharmaceuticals Stock Falling In Pre-market?

(RTTNews) – Vanda Pharmaceuticals (VNDA) said, on September 18, the FDA declined to approve New Drug Application of tradipitant for the treatment of symptoms in gastroparesis, providing the company with a Complete Response Letter. Vanda said it will continue to pursue the marketi

admin